vs
Side-by-side financial comparison of TAKEDA PHARMACEUTICAL CO LTD (TAK) and Telix Pharmaceuticals Ltd (TLX). Click either name above to swap in a different company.
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived th...
Telix Pharmaceuticals Ltd is a global clinical-stage biopharmaceutical company specializing in the development and commercialization of targeted radiopharmaceutical products for oncology. Its core portfolio covers diagnostic imaging agents and therapeutic treatments for prostate, renal, and neuroendocrine cancers, serving markets across North America, Europe, and Asia-Pacific.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 25 | $4.3M | — | ||
| Q1 24 | $4.0M | — |
| Q2 25 | $144.2K | — | ||
| Q1 24 | $317.0K | — |
| Q2 25 | 66.5% | — | ||
| Q1 24 | 69.1% | — |
| Q2 25 | 5.0% | — | ||
| Q1 24 | 12.2% | — |
| Q2 25 | 3.4% | — | ||
| Q1 24 | 7.9% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
